Steven Park to Receptors, CCR4
This is a "connection" page, showing publications Steven Park has written about Receptors, CCR4.
Connection Strength
0.696
-
Moore DC, Elmes JB, Shibu PA, Larck C, Park SI. Mogamulizumab: An Anti-CC Chemokine Receptor 4 Antibody for T-Cell Lymphomas. Ann Pharmacother. 2020 Apr; 54(4):371-379.
Score: 0.696